Member Info for Rocky500

Most of te 230k was buys under the mid price. Cant say the exact amount as wasnt paying that much attention but its funny that people will use the inaccurate nature of the information to suit their argument.

That's true.

Carl has given it credibility and visibility for me, his presentations have been excellent. I spoke to Viv late last year and got the impression the policy of walk before you run and talk before you shout was at the core. This has led to the PR being more muted than others...but over time has created a refreshing honesty I think.

Very true but I find it odd that someone can be so focused on one company that, whilst having a potentially good product is currently 23x mcap than that here which is on the cusp of revealing what could also be a very compelling offer. I think avct could introduce a good product but would never invest in it now simply because the mcap is too high. There may still be some growth to be had but its open to more downside than upside I would suggest...not a problem and I'm not so single minded to **** it off but not for me either.

I do but some people are kicking the gift horse in the mouth and literally wasting their time dribbling trash on here when they are neither invested or have anything useful to offer. Occasionally one needs to speak up.

Just reading that statement highlights how cynical and bordering on stupid hewhodares is. If there was no value creation going on then fine but if you just follow the directors lead and see what is going on then one is likely to make money rather than moan about someone else making it. Kind of sad.

Exactly and its directors are also investors and therefore will sell into strength and not have a cut and run policy so selling is to be expected. It's a case of seeing the pattern - assuming no external factors create problems the directors will be looking to rebuild the strength they have recently sold into by progressing the paraytec story to plan. This should increase the sp and if, as appears to be the case the covid test genuinely is as good as it is being billed then there will be genuine value creation in the company which will only go to support the director strategy of selling in stages in a rising SP market. TB is not going to kill his golden goose, more nurture it as much as possible. Kind of obvious really.

Not in the slightest, I'm right but not everyone has the foresight I do...and with that I get bored easily and move on to something a little more engaging.

Bored now.

Think you are being narrow minded one trick pony...world doesn't work that way. Quality wins out ultimately and finds its place.

Not critiquing LFT, they both have a place in future roll out. PCR is fine as a smaller scale, refined process but it's complex. BRH is a hybrid between PCR and LFT which makes it a compelling and unique offer.

120

And also PCR is not currently available in around 129 seconds...

You've obviously not seen the high volume matrix presentation that Carl did. But ultimately PCR can't be deployed as easily as the BRH kit (that's the plan anyway) and the main kit should be quite a bit less than the PCR set up.

Also by controlling the tests and who records the result the whole process is manageable and predictable. LFT is fine but it is quite basic in its deployment, both a plus but also a minus. Its not comparing apples with apples.

LFT will likely settle in future in a similar way to pregnancy testa - pick them up at the pharmacy and use them at home. Paraytec kit is more to buy but will likely turn up in every hospital, lab and doctors surgery as well as commercial locations if its proven in time

Because you need a clinician to work PCR, the Paraytec kit is similar to the drug / explosive kit- can be used by anyone pretty much. You just need to make sure you don't drop it as its sensitive kit.

The equipment will look similar to the explosive / drug detection equipment - the cost is buying the kit but if you use it enough the cost per test is peanuts.

And it does have the option for quantification of viral load beyond the standard yes/no answer (as per Paraytec website)

You missed my point - the BRH equipment can be used with cartridges developed for a huge range of different pathogens. It's like a nespresso machine for diagnostics....and we know how successful nespresso has been!

The Paraytec test will likely complement the LFT not compete against it to start as they have very different application strengths. Chances are the individual cartridge cost off the Paraytec test will be less than the LFT but the kit will cost to start with. The Paraytec test is far more adaptable than the LFT and therefore will appeal as a proper piece of diagnostic equipment. If it works as well as it is being suggested it could revolutionise the diagnostics industry whereas the LFT is, as Carl put it the filler to enable the world to get back to work until something permanent comes along.